Peak Bio, Inc. (PKBO)

Peak Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021
Cash & Equivalents	0.65	0.21
Cash & Cash Equivalents	0.65	0.21
Cash Growth	218.72%	-
Other Current Assets	2.58	0.25
Total Current Assets	3.23	0.46
Property, Plant & Equipment	4.06	0.38
Other Long-Term Assets	0.24	0.24
Total Long-Term Assets	4.3	0.62
Total Assets	7.53	1.08
Accounts Payable	3.62	0.3
Deferred Revenue	4.86	0
Current Debt	2.1	0
Other Current Liabilities	0.23	2.49
Total Current Liabilities	10.8	2.79
Long-Term Debt	3.51	0
Other Long-Term Liabilities	1.32	0.22
Total Long-Term Liabilities	4.82	0.22
Total Liabilities	15.62	3.01
Total Debt	5.6	0
Common Stock	0	0
Retained Earnings	-25.35	-8.45
Comprehensive Income	0.03	0.09
Shareholders' Equity	-8.09	-1.94
Total Liabilities and Equity	7.53	1.08
Net Cash / Debt	-4.95	0.21
Net Cash Per Share	-0.28	0.01
Working Capital	-7.57	-2.33
Book Value Per Share	-0.46	-0.11

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.